Delivery Order SPE2DR25D7066-SPE2DR26F7ZGR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $4,677.22. This is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $2,738.77. This is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and represents performance at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $5,707.80. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was awarded on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This $4,480.59 firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026. No set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,249.56. This firm fixed-price delivery order, which was not set-aside and competitively awarded, was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $1,495.78 and an ultimate completion date of November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $4,651.20. This competitive award, executed on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies a performance location in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,732.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZGRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,341.44 and ultimate completion date of November 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical devices to support military and federal healthcare systems. The company's extensive federal contracting portfolio demonstrates its critical role in providing emergency medical supplies, specialty pharmaceuticals, and other healthcare commodities to defense and civilian federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/24/25 |